Ricky Hopson, President Clinical Development Supply Division at Catalent, Inc. (CTLT), sold 643 shares at $49.36 ($32K) on 2023-01-23, disclosed to the SEC on 2023-01-25.
Open-market sale of $32k CTLT by President Clinical Development Supply Division. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| CTLT | SELL | 2024-06-05 | $152K | — | Filing → |
| CTLT | SELL | 2023-08-25 | $12K | — | Filing → |
| CTLT | SELL | 2023-08-03 | $9K | — | Filing → |